Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Cipio Partners names Maximilian Schroeck Managing Partner and opens US office

Munich/London/San Jose, August 24, 2005 – Cipio Partners, a leading secondary direct investment firm, announced today that Maximilian Schroeck has joined as Managing Partner to head up the firm's newly opened office in San Jose, CA.

Maximilian Schroeck joins Cipio Partners from Agilent Technologies, Palo Alto, CA, where he served as Managing Director Agilent Ventures, overseeing Agilent’s global venture investments in communication and measurement technologies as well as life sciences. Maximilian was also in charge of Agilent's corporate strategy group and new business development program, where he launched and managed efforts in nano-scale measurement and other emerging technology areas. Before joining Agilent in early 2001, Maximilian spent more than 10 years with A.T. Kearney, a global management consulting firm, in the US and in Europe advising many of the world's leading high technology companies on corporate strategy issues around growth, innovation and operational effectiveness. Maximilian holds MBA and Doctorate degrees in Strategic Management from Munich University, Germany.

Werner Dreesbach, a Managing Partner at Cipio, says: “We are extremely pleased to have Maximilian lead our US efforts. He has extensive industry as well as private equity experience and enjoys strong relationships with leading VCs in the US, Europe and Israel. Maximilian’s operating experience combined with his investment track record will be of immense value to Cipio’s portfolio.'

Currently, Cipio Partners manages a portfolio of investments in close to 60 companies in Software, Semiconductor, Communications and Life Sciences. The addition of Maximilian Schroeck takes Cipio Partners to a total of 11 professionals. With the opening of its office in San Jose, Cipio Partners puts in place the necessary local infrastructure to actively manage its North American investees and pursue further portfolio acquisitions in the region.

Maximilian Schroeck comments: 'I am delighted to join the Cipio Partners team. In a short time, the firm has earned an excellent reputation as a hands-on investor and a leader in the secondary direct market. Secondary directs in the US is a very attractive investment opportunity for us and I intend to leverage our leadership position in Europe into quality portfolio transactions in the US. I certainly look forward to working with Cipio’s portfolio companies and our partners on the venture capital and corporate side.'

About Cipio Partners
Cipio Partners is a leading investment management firm in the secondary direct market. Founded in mid-2003, Cipio Partners manages an international portfolio of early and later-stage venture capital and mid-market investments out of offices in Munich and London. Representative portfolio companies include Broadbus Technologies, Danger and MontaVista Software in the US as well as Saifun Semiconductors and DiBcom in Europe. For more information, visit

Publisher Contact Information:

Cipio Partners GmbH
+49 (89) 5506 9646

Company profile of Cipio Partners GmbH
Past press releases of Cipio Partners GmbH.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
May 30€15.0MBiopharmaceuticals
May 28€15.0MDiagnostics
May 28€1.3MInternet services
May 25€1.0MOther Software
May 22N/AInternet services
May 20€4.3MArtificial Intelligence

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.